SEC Filings | Aerie Pharmaceuticals, Inc
Aerie Pharmaceuticals – Capital Sign Solutions
Investor Relations | Aerie Pharmaceuticals, Inc
Ophthalmology Innovation Showcase 1 - Aerie Pharmaceuticals
Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals
Aerie Pharmaceuticals, Inc.
Aerie Pharma appoints Richard Rubino as CFO | Procurement & Supply Chain | Healthcare Global
Aerie Pharmaceuticals and Ramot at Tel Aviv University Enter Research Collaboration | Business Wire
Aerie Pharmaceuticals Inc (AERI) Q3 2020 Earnings Call Transcript
Rise in the sentiment of investors in Aerie Pharmaceuticals INC. – Medgazette 24
FDA OK of Aerie Pharma glaucoma drug jeopardized by factory issues out of its control
Durham's Aerie Pharma raises $316.5M, to use funds for eye disease drug development | WRAL TechWire
Aerie
Aerie-Pharma -
Aerie Pharmaceuticals to Present at Two Investor Conferences in March | Business Wire
Aerie Pharma on go with mid-stage study of eye drop for dry eye (NASDAQ:AERI) | Seeking Alpha
Aerie Pharmaceuticals Inc - AnnualReports.com
Cantor Initiates Aerie Pharma At Buy: 'Wouldn't Be Surprised If Aerie Became Takeover Candidate'
Aerie Pharma (AERI) Provides 2020 Company and Guidance Update Associated with COVID-19
Durham-based Aerie Pharma sees positive study results for eye pressure drug | WRAL TechWire
Aerie-Pharma -
Aerie Pharma: Significantly Derisked (NASDAQ:AERI) | Seeking Alpha
Aerie Pharma's CMO Receives FDA CRL - Contract Pharma
Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals
